MedPath

Sodium chloride

Generic Name
Sodium chloride
Brand Names
Amphenol-40, As 3, Bi-peglyte, Bicart, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Clinimix E 2.75/5, Colyte, Corvatrol, Dextrose and Electrolyte No. 75, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hemosate Ultra, Hespan, Hizentra, Hyperlyte, Intersol, Isolyte S, Isolyte S pH 7.4, Isoplate, Lactate 1-2-3, Lactated Ringers, Menopur, Moviprep, Muro 128, Naturalyte, Normosol-M, Normosol-R, Nulytely, Nxstage Pureflow, P-Care M, P-Care MG, P-care, P-care X, Peglyte, Phoxillum, Physiolyte, Physioneal 40, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Prismasol, Procalamine 3, Ringers, Sag-M, Sclerodex, Suflave, Tis-U-sol
Drug Type
Small Molecule
Chemical Formula
ClNa
CAS Number
7647-14-5
Unique Ingredient Identifier
451W47IQ8X

Overview

Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential Medicines.

Background

Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential Medicines.

Indication

This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.

Associated Conditions

  • Allergic Rhinitis (AR)
  • Corneal Edema
  • Dehydration
  • Dehydration Hypertonic
  • Fluid Loss
  • Hemodilution
  • Hypokalemia
  • Hyponatremia
  • Hypotonic Dehydration
  • Hypovolaemia
  • Increase in Intracranial Pressure (ICP)
  • Increased Intra Ocular Pressure (IOP)
  • Inflammation of the Nasal Mucosa
  • Isotonic Dehydration
  • Metabolic Acidosis
  • Nasal Congestion
  • Nasal irritation
  • Oliguria caused by Acute Renal Failure (ARF)
  • Potassium deficiency
  • Sinusitis
  • Skin Irritation
  • Sodium Depletion
  • Dryness of the nose
  • Hypochloremic state
  • Mild Metabolic acidosis
  • Mild, moderate Metabolic Acidosis

Clinical Trials

Phase 4
Completed
Posted: 2024/07/10
Sponsor:
Haseki Training and ...
Phase 2
Recruiting
Posted: 2024/03/12
Sponsor:
Gabriella Milos
Phase 1
Active, not recruiting
Posted: 2024/03/08
Sponsor:
Martin Blomberg Jens...

FDA Approved Products

Potassium Chloride in Dextrose and Sodium Chloride
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:2.25 g in 1000 mL
Approved: 2017/03/02
NDC:65219-153
Sodium Chloride
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:4.5 g in 1000 mL
Approved: 2019/05/29
NDC:0338-0043
AS 3
Manufacturer:Terumo BCT Ltd
Route:INTRAVENOUS
Strength:0.41 g in 100 mL
Approved: 2018/12/04
NDC:14537-966
BSS
Manufacturer:Alcon Laboratories, Inc.
Route:OPHTHALMIC
Strength:6.4 mg in 1 mL
Approved: 2016/01/28
NDC:0065-0795
Sodium chloride
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:9 mg in 1 mL
Approved: 2023/08/02
NDC:65219-282

Singapore Approved Products

SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9%
Manufacturer:B BRAUN MEDICAL INDUSTRIES SDN BHD, B BRAUN MELSUNGEN AG, B.Braun Medical S.A., B. Braun Melsungen AG (LIFE plant), PT. B.BRAUN PHARMACEUTICAL INDONESIA
Form:INJECTION
Strength:0.9 g/100 ml
Online:Yes
Approved: 1991/05/18
Approval:SIN05951P
SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9%
Manufacturer:P T OTSUKA INDONESIA
Form:INJECTION
Strength:0.9 g/100 ml
Online:Yes
Approved: 1991/06/11
Approval:SIN06282P
COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Manufacturer:B BRAUN MEDICAL INDUSTRIES SDN BHD, B. Braun Melsungen AG, B. Braun Medical SA
Form:INJECTION
Strength:0.6 g/100 ml
Online:Yes
Approved: 1991/07/08
Approval:SIN06429P
BAXTER-SODIUM CHLORIDE INJECTION USP 0.9% W/V
Manufacturer:Baxter Healthcare Philppines, Inc.
Form:INFUSION, SOLUTION
Strength:900mg per 100mL
Online:Yes
Approved: 2022/09/14
Approval:SIN16603P
DEXTROSE 5% AND SODIUM CHLORIDE 0.2% INJECTION USP
Manufacturer:BAXTER HEALTHCARE CORPORATION
Form:INJECTION
Strength:200 mg/100 ml
Online:Yes
Approved: 1991/04/08
Approval:SIN05730P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath